Deals
Maker of At-Home Covid Test Seeks Funds at $1 Billion Valuation
- Won emergency FDA approval for home Covid-19 test in May
- Tele-health companies are rushing to expand in the pandemic
Source: Everlywell in.
This article is for subscribers only.
Everlywell Inc., a health startup that sells a Covid-19 home-testing kit, is in talks to raise fresh capital at a valuation of $1 billion or more.
Prospective investors including venture capital firms are participating in the discussions, according to a person familiar with the matter who asked not to be named. The company reached a valuation of $175 million after a fundraising round last year, according to Pitchbook estimates.